Posts in: NCT

Damien Perriman interviewed for Springwise
press clippingsperrimanNCT
Springwise case study: Unpacking how eXoZymes and Cayman Chemical are rethinking chemical manufacturingApril 17, 2026
Grow Everything podcast featuring Damien Perriman
press releasenutraceuticalsmedicinepress clippingsvideosciencepodcastperrimanNCT
eXoZymes CCO, Damien Perriman, outlines NCTx strategy and the commercial path for cell-free biomanufacturing on Grow Everything podcastApril 10, 2026
The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss Drugs
nutraceuticalspress clippingsNCT
Village Voice: The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss DrugsApril 9, 2026
Perriman at Nasdaq
investornutraceuticalsmedicinepress clippingsvideoperrimanNCT
Nasdaq: Damien Perriman interview on NCTApril 2, 2026
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026
investornutraceuticalsmedicinevideoNCTcannabinoids
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026April 1, 2026
eXoZymes de-risks scale-up with Cayman Chemical, validating tech transfer with pharma-grade output
investornutraceuticalsmedicineperrimanNCT
EXOZ investor update: eXoZymes de-risks scale-up with Cayman Chemical, validating tech transfer with pharma-grade outputMarch 18, 2026
Video interview: Cayman Chemical validates eXoZymes' technology and scalability
press releasenutraceuticalsmedicinevideoperrimanNCT
Video interview: Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalabilityMarch 18, 2026
2026 MISTA Symposium Healthspan
press releasenutraceuticalsmedicineperrimanNCT
eXoZymes’ CCO Damien Perriman to Present a NCT solution at next week’s MISTA SymposiumMarch 12, 2026
Pharma-grade NCT ready for partner testing
press releaseinvestornutraceuticalsscienceNCT
eXoZymes advancing commercial readiness with profound production metrics on initial NCT pilot runJanuary 29, 2026
100× scale-up of NCT production achieved
heltzenpress releaseinvestornutraceuticalsmedicineNCTkorman
eXoZymes achieves 100× scale-up of NCT production using exozymes, demonstrating near-perfect feedstock conversionDecember 11, 2025
Previous page
Page 1 of 2
Next page